RepMatter vs OpenEvidence
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
RepMatter
This app facilitates collaboration for medical professionals by connecting them with relevant people and topics. It allows company representatives to onboard clinicians to a global knowledge and discussion platform, offering insights into product and therapy usage within a controlled environment.
- Personalized content feed
- Clinician onboarding
- Industry insights
- Controlled discussion environment
- Global knowledge platform
- Opt-in industry engagement
Read full descriptionHide full description
DocMatter has reimagined collaboration for the medical professional community. We've done this in part by moving away from traditional open forums and thus providing individual clinicians and researchers with an experience based entirely on the people and topics that interest them. RepMatter is the industry portal for the DocMatter platform. The RepMatter app empowers company representatives to invite and onboard clinicians to DocMatter, giving those clinicians access to the largest global knowledge and discussion platform for health care professionals. The RepMatter app allows company representatives the unique opportunity to better understand how their products and therapies are used by clinicians. DocMatter has robust protections in place to ensure the platform is fully controlled and owned by the clinician community. Through RepMatter, industry access is limited to discussions among providers who have opted-in to engaging directly with company-supported education. Company representatives have no ability to start or steer discussions, ensuring a safe and trusted environment for clinicians to collaborate, while at the same time providing industry the insights needed to improve education, rep training, R&D and much more. If you’d like to know more about joining the DocMatter platform, contact us any time at info@docmatter.com or 1-855-DOC-MATTER.
OpenEvidence
This app provides healthcare professionals with evidence-based clinical decision support and medical information. It acts as a search engine, sourcing answers from peer-reviewed literature and leading medical organizations to aid in high-stakes medical decisions at the point of care.
- Clinical decision support
- Medical search engine
- Sourced from peer-reviewed literature
- FDA and CDC data integration
- Partnerships with leading medical journals
- Verified healthcare professional access
Read full descriptionHide full description
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required) OpenEvidence is the most widely used clinical decision support platform and medical search engine among U.S. clinicians. According to independent studies, more American physicians use OpenEvidence than all other AI platforms combined. OpenEvidence is trusted by millions of verified healthcare professionals to make high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. Founded with the mission to organize and expand the world's collective medical knowledge, OpenEvidence is actively used daily by the majority of physicians in the United States. OpenEvidence is free for all verified U.S. clinicians. AN OFFICIAL AI PARTNER OF: The New England Journal of Medicine (NEJM) The Journal of the American Medical Association (JAMA) and its 11 specialty journals National Comprehensive Cancer Network (NCCN) Nature Cochrane Library Wiley WHAT YOU GET: • Specific answers to clinical questions, with every claim cited to its source • 35 million+ peer-reviewed papers, 300+ medical journals, plus FDA and CDC sources • Licensed full text from NEJM, JAMA, Nature, Cochrane, and others • EvidenceGrade™: see the strength of the evidence behind every answer • CME and MOC credits, earned by asking questions • Visits for ambient documentation, Dialer for secure patient calls, and Voice Mode for hands-free answers CONTENT AGREEMENTS AND COLLABORATIONS: American Academy of Family Physicians (AAFP) American College of Cardiology (ACC) American Diabetes Association (ADA) American Academy of Pediatrics (AAP) American College of Obstetricians and Gynecologists (ACOG) American College of Emergency Physicians (ACEP) ASCO Guidelines American Academy of Orthopaedic Surgeons (AAOS) American Academy of Ophthalmology (AAO) American Urological Association (AUA) Plus AAO-HNS, GINA, SNO, SSO, and more. IN USE ACROSS: 10,000+ hospitals and medical centers nationwide, including Mayo Clinic, Mount Sinai, Cedars-Sinai, MSKCC, and Sutter Health. WHY CLINICIANS TRUST US: • HIPAA compliant across the platform • NEJM, JAMA, Nature, and NCCN—official content partners • Tens of millions of clinical consultations per month WHAT CLINICIANS SAY: “OpenEvidence is currently the best AI tool for medical information.” — Dr. Paul Sax, Infectious Disease, Brigham and Women’s Hospital, Review in The New England Journal of Medicine Journal Watch (now NEJM Clinician) “In a morning report, a resident had a question that I didn’t know the answer to, but we were able to open OpenEvidence and get an answer on the spot.” — Dr. Kyle P. Lehenbauer, Minneapolis Veterans Affairs Medical Center “I use OpenEvidence multiple times during the day and every day. I am a better doc because of this. I expand my differential diagnoses and verify the science behind choices of treatments.” — Dr. Sharon E. Martin, Southern Huntingdon Medical Center Important note: OpenEvidence is available only to healthcare professionals. Users must verify their healthcare professional status before using OpenEvidence.
Screenshots
Verdict
The clearest difference is rating: OpenEvidence at 4.9 against RepMatter's 4.0. OpenEvidence also leads on update cadence (weekly vs every 3 months) and ratings volume (12K vs 5). RepMatter's advantage is iOS requirement (12.0 vs 15.1). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
OpenEvidence holds the better App Store score, 4.9 against 4.0. That said, the two scores are not equally well evidenced: OpenEvidence has 12K ratings behind it against 5, so its average is the more settled of the two.
RepMatter ships an update every 3 months, OpenEvidence weekly. The most recent releases landed on October 13, 2026 and October 29, 2026 respectively.
| Parameter | RepMatter | OpenEvidence |
|---|---|---|
| Price | Free | Free |
| Rating | 4.0 (5 ratings) | 4.9 (12K ratings) — better |
| Positive reviews | — | 81.0% of reviews |
| Number of ratings | 5 | 12K — better |
| Update frequency | Every 3 months | Weekly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Best chart rank | — | #34 — better |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 32 MB | 95 MB |
| Age rating | 12+ | +17 |
| Developer | DocMatter Inc. | OpenEvidence Inc. |
Customer experience
RepMatter
OpenEvidence
Bugs and requests
RepMatter
Not enough reviews yet to summarise bugs or requests.
OpenEvidence
Reported bugs
1 issue- App not working in latest update
Requested features
2 requests- Availability on MacBook
- Integration with clinical workflows and EMRs
In-app purchases
RepMatter
No in-app purchases
OpenEvidence
No in-app purchases









